KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Non Operating Income: 2014-2025

Historic Non Operating Income for Exact Sciences (EXAS) over the last 12 years, with Sep 2025 value amounting to $7.8 million.

  • Exact Sciences' Non Operating Income rose 294.33% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year decrease of 82.17%. This contributed to the annual value of $12.5 million for FY2024, which is 5.46% down from last year.
  • Exact Sciences' Non Operating Income amounted to $7.8 million in Q3 2025, which was up 272.45% from $2.1 million recorded in Q2 2025.
  • Over the past 5 years, Exact Sciences' Non Operating Income peaked at $26.6 million during Q1 2021, and registered a low of -$13.8 million during Q3 2022.
  • Moreover, its 3-year median value for Non Operating Income was $2.0 million (2024), whereas its average is $2.8 million.
  • As far as peak fluctuations go, Exact Sciences' Non Operating Income slumped by 572.94% in 2022, and later soared by 498.39% in 2024.
  • Quarterly analysis of 5 years shows Exact Sciences' Non Operating Income stood at -$3.4 million in 2021, then tumbled by 224.47% to -$11.0 million in 2022, then spiked by 258.13% to $17.5 million in 2023, then slumped by 97.80% to $385,000 in 2024, then soared by 294.33% to $7.8 million in 2025.
  • Its Non Operating Income stands at $7.8 million for Q3 2025, versus $2.1 million for Q2 2025 and -$5.0 million for Q1 2025.